[The ileocoecal valve changes in chronic constipation in children]

Insights

This study found that magnesium orotate treatment effectively resolved chronic constipation in most children with ileocecal valve insufficiency. Younger patients generally showed better outcomes from conservative management.

Area of Science:

  • Pediatric Gastroenterology
  • Colorectal Surgery
  • Pharmacology

Context:

  • Chronic constipation affects children with anatomical large bowel anomalies.
  • Ileocecal valve (IV) insufficiency is a specific condition noted in some pediatric cases.
  • Evaluating treatment efficacy for complex pediatric gastrointestinal issues is crucial.

Purpose:

  • To assess the effectiveness of conservative treatment, including magnesium orotate, for chronic constipation in children with anatomical large bowel anomalies and IV insufficiency.
  • To determine the success rate of conservative versus surgical interventions.
  • To explore the relationship between patient age and treatment outcomes.

Summary:

  • A study analyzed 574 children with chronic constipation due to large bowel anomalies, identifying 61 with ileocecal valve (IV) insufficiency.
  • Patients received conservative treatment including magnesium orotate to address IV insufficiency.
  • Conservative treatment was effective in 91.8% of cases, with only 5 requiring surgery, indicating a negative correlation between age and treatment success.

Impact:

  • Highlights the efficacy of magnesium orotate in managing pediatric chronic constipation associated with IV insufficiency.
  • Suggests conservative management is highly successful, reducing the need for surgical intervention in many cases.
  • Provides evidence for age-related differences in treatment response for this pediatric population.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...